Junjun Shen
10 Papers
23 Citations
Junjun Shen is an academic researcher. The author has contributed to research in topics: Oncogene & Cancer. The author has an hindex of 5, co-authored 7 publications.
Chat about Author
Papers
Potential screening and early diagnosis method for cancer: Tongue diagnosis
TL;DR: It is suggested that tongue diagnosis may provide potential screening and early diagnosis method for cancer through evaluating the differences of the images of tongue and tongue coating and the microbiome on the tongue coating.
Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy.
Yizhen Jiang,Xiaoxuan Tu,Xiangying Zhang,Haihong Liao,Shuwen Han,Weiqin Jiang,Yi Zheng,Peng Zhao,Zhou Tong,Qihan Fu,Quan Qi,Junjun Shen,Liping Zhong,Yuefen Pan,Weijia Fang +14 more
TL;DR: Examination of nutrition and metabolism status alteration during immunotherapy in advanced hepatocellular carcinoma patients suggested that ALB and PNI were positively correlated with the efficacy of immunotherapy, and survival analysis showed that the median progression-free survival and median overall survival of patients in the ALB/PNI decreased group were significantly shorter than those of patients from the ALb/PNi increased group.
23
MicroRNA‑874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1
Haihong Liao,Yun-Fei Pan,Yuefen Pan,Junjun Shen,Quan Qi,Liping Zhong,Wenshu Han,Qi Wang,Yizhen Jiang +8 more
TL;DR: The results of the present study indicated that miR‑874 may serve as a tumour suppressor in cervical cancer by directly targeting ETS1.
L-securinine inhibits the proliferation of A549 lung cancer cells and promotes DKK1 promoter methylation.
TL;DR: L-securinine induced the downregulation of DKK1 in A549 cells in a dose-dependent manner and induced methylation changes at CpG sites in the DKK 1 promoter region, suggesting it may be a potential anticancer drug that mediates its effects by altering DKK2 gene methylation.
FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.
TL;DR: In this article, the role of FBXW7 in the invasion, migration and angiogenesis of ovarian cancer (OC) cells, and to identify its potential molecular mechanisms were investigated.